APA

Read M. L., Fong J. C., Modasia B., Fletcher A., Imruetaicharoenchoke W., Thompson R. J., Nieto H., Reynolds J. J., Bacon A., Mallick U., Hackshaw A., Watkinson J. C., Boelaert K., Turnell A. S., Smith V. E. & McCabe C. J. (20171013). Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer. : Oncogene.

Chicago

Read M L, Fong J C, Modasia B, Fletcher A, Imruetaicharoenchoke W, Thompson R J, Nieto H, Reynolds J J, Bacon A, Mallick U, Hackshaw A, Watkinson J C, Boelaert K, Turnell A S, Smith V E and McCabe C J. 20171013. Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer. : Oncogene.

Harvard

Read M. L., Fong J. C., Modasia B., Fletcher A., Imruetaicharoenchoke W., Thompson R. J., Nieto H., Reynolds J. J., Bacon A., Mallick U., Hackshaw A., Watkinson J. C., Boelaert K., Turnell A. S., Smith V. E. and McCabe C. J. (20171013). Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer. : Oncogene.

MLA

Read M L, Fong J C, Modasia B, Fletcher A, Imruetaicharoenchoke W, Thompson R J, Nieto H, Reynolds J J, Bacon A, Mallick U, Hackshaw A, Watkinson J C, Boelaert K, Turnell A S, Smith V E and McCabe C J. Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer. : Oncogene. 20171013.